Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Email this article to a friend

Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer

Carlos L Arteaga email

Breast Cancer Res 2003, 5:96-100doi:10.1186/bcr574

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.